Literature DB >> 4604290

Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis.

A S Fauci, D C Dale, S M Wolff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604290     DOI: 10.1002/art.1780170404

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

1.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.

Authors:  Rémi Goupil; Soumeya Brachemi; Annie-Claire Nadeau-Fredette; Clément Déziel; Yves Troyanov; Valery Lavergne; Stéphan Troyanov
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

3.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

4.  Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.

Authors:  L P Zhu; T R Cupps; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

5.  Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.

Authors:  Åsa Cm Johansson; Sophie Ohlsson; Åsa Pettersson; Anders A Bengtsson; Daina Selga; Markus Hansson; Thomas Hellmark
Journal:  Arthritis Res Ther       Date:  2016-04-22       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.